1069 related articles for article (PubMed ID: 17936815)
1. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
2. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
3. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
4. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
[TBL] [Abstract][Full Text] [Related]
5. Focal therapy for prostate cancer.
Polascik TJ; Mouraviev V
Curr Opin Urol; 2008 May; 18(3):269-74. PubMed ID: 18382236
[TBL] [Abstract][Full Text] [Related]
6. Re: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Ahmed HU; Emberton M
J Urol; 2008 Aug; 180(2):780-1; author reply 781-3. PubMed ID: 18555492
[No Abstract] [Full Text] [Related]
7. Pathology of prostate cancer and focal therapy ('male lumpectomy').
Mazzucchelli R; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Kirkali Z; Montironi R
Anticancer Res; 2009 Dec; 29(12):5155-61. PubMed ID: 20044631
[TBL] [Abstract][Full Text] [Related]
8. Conventional treatments of localized prostate cancer.
Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
[TBL] [Abstract][Full Text] [Related]
9. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation.
Marberger M
Curr Opin Urol; 2007 May; 17(3):194-9. PubMed ID: 17414518
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
11. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
12. The current use and future trends of focal surgical therapy in the management of localized prostate cancer.
Barqawi AB; Crawford ED
Cancer J; 2007; 13(5):313-7. PubMed ID: 17921730
[TBL] [Abstract][Full Text] [Related]
13. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.
Mouraviev V; Mayes JM; Sun L; Madden JF; Moul JW; Polascik TJ
Cancer; 2007 Aug; 110(4):906-10. PubMed ID: 17587207
[TBL] [Abstract][Full Text] [Related]
15. Focal therapy for clinically localized prostate cancer.
Marchetti P; Eggener S
Arch Esp Urol; 2011 Oct; 64(8):815-22. PubMed ID: 22052762
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive disease.
Klotz LH
Can J Urol; 2005 Feb; 12 Suppl 1():53-7; discussion 101-2. PubMed ID: 15780167
[TBL] [Abstract][Full Text] [Related]
17. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
van der Kwast TH; Hoedemaeker RF; Schröder FH
Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
[TBL] [Abstract][Full Text] [Related]
19. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
Christie D; Denham J; Steigler A; Lamb D; Turner S; Mameghan H; Joseph D; Matthews J; Franklin I; Atkinson C; North J; Poulsen M; Spry NA; Tai KH; Wynne C; Duchesne G; Kovacev O; Francis L; Kramar A; D'Este C; Bill D
Radiother Oncol; 2005 Nov; 77(2):117-25. PubMed ID: 16271786
[TBL] [Abstract][Full Text] [Related]
20. Failure of focal prostate cancer on biopsy to predict focal prostate cancer: the importance of prevalence.
Weldon VE; Tavel FR; Neuwirth H; Cohen R
J Urol; 1995 Sep; 154(3):1074-7. PubMed ID: 7543602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
